Efficacy and safety of Chinese herbal medicine for benign prostatic hyperplasia

Autor: Chun Ho Ma et al.

Journal: Asian J Androl. 2013 Jul;15(4):471-82, englisch

Efficacy and safety of Chinese herbal medicine for benign prostatic hyperplasia: Systematic reviewers of randomized controlled trials

Chinese herbal medicine is commonly used as a treatment for benign prostatic hyperplasia (BPH), but its efficacy and safety remain to be examined. To compare the efficacy and adverse events of Chinese herbal medicine alone or used adjuvantly with Western medications for BPH. Two independent reviewers searched the major electronic databases for randomized controlled trials comparing Chinese herbal medicine, either in single or adjuvant use with Western medication, with placebo or Western medication.

Relevant journals and grey literature were also hand-searched. The outcome measures included changes in urological symptoms, urodynamic measures, prostate volume and adverse events. The frequency of commonly used herbs was also identified. Out of 13 922 identified citations of publications, 31 studies were included. Eleven studies with a Jadad score ≥3 were selected for meta-analysis. Chinese herbal medicine was superior to Western medication in improving quality of life and reducing prostate volume. The frequency of adverse events in Chinese herbal medicine was similar to that of placebo and less than that of Western medication.

The evidence is too weak to support the efficacy of Chinese herbal medicine for BPH due to the poor methodological quality and small number of trials included. The commonly used herbs identified here should provide insights for future clinical practice and research. Larger randomized controlled trials of better quality are needed to truly evaluate the efficacy of Chinese herbal medicine.

Andere Benutzer haben sich neben diesem auch noch folgende Artikel angesehen:

Jianpi Bushen, a Traditional Chinese Medicine Therapy, Combined with Chemotherapy for Gastric Cancer Treatment
Yunbo Chen et al.; 2018

Efficacy of Chinese herbal medicine for stroke modifiable risk factors
Wenbo Peng et al.; 2017

Chinese herbal treatment delivered by GPs compared with individualised treatment for women with recurrent urinary tract infections
Flower Andrew et al.; 2016


Vorheriger Artikel


Nächster Artikel

Link zum Journal